Exploring imidazo[4,5-g]quinoline-4,9-dione derivatives as Acinetobacter baumannii efflux pump inhibitor: an in silico approach

P Brindangnanam, K Ashokkumar… - Journal of …, 2023 - Taylor & Francis
Antimicrobial resistance (AMR) is fast becoming a medical crisis affecting the entire global
population. World Health Organization (WHO) statistics show that globally 0.7 million people …

In silico high-throughput virtual screening and molecular dynamics simulation study to identify inhibitor for AdeABC efflux pump of Acinetobacter baumannii

P Verma, M Tiwari, V Tiwari - Journal of Biomolecular Structure and …, 2018 - Taylor & Francis
Emergence of multi-drug resistant strains of Acinetobacter baumannii has caused significant
health problems and is responsible for high morbidity and mortality. Overexpression of …

In silico screening and in vitro validation of phytocompounds as multidrug efflux pump inhibitor against E. coli

Samreen, FA Qais, I Ahmad - Journal of Biomolecular Structure and …, 2023 - Taylor & Francis
Multiple drug resistance (MDR) in bacteria has increased globally in recent times. This has
reduced the efficacy of antibiotics and increasing the rate of therapeutic failure. Targeting …

Virtual screening and biological activity evaluation of novel efflux pump inhibitors targeting AdeB

Y Tuo, Y Tang, R Yang, XM Zhao, M Luo, X Zhou… - International Journal of …, 2023 - Elsevier
The AdeABC efflux pump is an important mechanism causing multidrug resistance in
Acinetobacter baumannii, and its main component AdeB can recognize carbapenems …

Targeting outer membrane protein component AdeC for the discovery of efflux pump inhibitor against AdeABC efflux pump of multidrug resistant Acinetobacter …

P Verma, V Tiwari - Cell Biochemistry and Biophysics, 2018 - Springer
The structure and functioning of multidrug efflux systems provide us with a better
understanding of the transport of various antibiotics, thus giving a path for the discovery of …

RND pump inhibition: in-silico and in-vitro study by Eugenol on clinical strain of E. coli and P. aeruginosa

EE Ashtiani, Z Gholizadeh Siahmazgi, M Mirpour… - In Silico …, 2023 - Springer
Abstract Multidrug-resistant (MDR) gram-negative bacteria pose significant challenges to the
public health. Various factors are involved in the development and spread of MDR strains …

Computational assessment and in vitro test of phytochemicals of Usnea aciculifera as potential inhibitors of Escherichia coli efflux pump AcrB

TV Phan, LT Tuong, VTV Nguyen, CVT Vo… - Journal of …, 2023 - Taylor & Francis
Lichens produce secondary metabolites that have many pharmaceutical activities such as
antimicrobial, antioxidant, antiviral, anticancer, antigenotoxic, anti-inflammatory, analgesic …

In-silico interaction studies suggest RND efflux pump mediates polymyxin resistance in Acinetobacter baumannii

P Verma, P Maurya, M Tiwari… - Journal of Biomolecular …, 2019 - Taylor & Francis
Bacterial efflux pumps have emerged as antibiotic resistance determinants and confers multi-
drug resistance to a broad range of antimicrobials as well as non-antibiotic substances. A …

Identification of efflux pump inhibitors for Pseudomonas aeruginosa MexAB-OprM via ligand-based pharmacophores, 2D-QSAR, molecular docking, and molecular …

TV Phan, VTV Nguyen, MT Le, BGD Nguyen, TT Vu… - Molecular Diversity, 2023 - Springer
Efflux pumps have been reported as one of the significant mechanisms by which bacteria
evade the effects of multiple antibiotics. The tripartite efflux pump MexAB-OprM in …

Discovering targeted inhibitors for Escherichia coli efflux pump fusion proteins using computational and structure‐guided approaches

SS Chauhan, A Gupta, A Srivastava… - Journal of …, 2024 - Wiley Online Library
Multidrug resistance pathogens causing infections and illness remain largely untreated
clinically. Efflux pumps are one of the primary processes through which bacteria develop …